Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Zydus Cadila scores twin FDA approvals

February 17, 2017 Medical Communications, Sales and Marketing FDA, Zydus Cadila

Indian pharmaceutical firm Zydus Cadila has announced that the US Food and Drug Administration (FDA) has given the go-ahead for …
News
takeda_tokyo_hq

Takeda and TiGenix announce successful trial of Crohn’s disease drug

February 17, 2017 Medical Communications, Sales and Marketing Takeda, TiGenix

Takeda and TiGenix announced Phase 3 results from a trial looking into the investigational compound Cx601, a treatment for refractory …
News
donald_trump_september_3_2015

What does Trump’s victory mean for the pharma, biotech and healthcare sectors?

February 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, Trump

After his first month in office and numerous threats to big pharma, finnCap Life Sciences analysts Alex Pye and Mark …
Feature
abbvie_0

NICE rejects AbbVie’s leukaemia drug

February 16, 2017 Sales and Marketing AbbVie

NICE has rejected AbbVie Venclyxto (venetoclax) for the treatment of chronic lymphocytic leukmaemia, on various grounds but primarily focusing upon …
News
facilities_lg06

Dr Reddy’s rocked by negative patent infringement ruling, shares hit one-year low

February 16, 2017 Sales and Marketing Dr Reddy's Laboratories, Helsinn Healthcare

India-based pharmaceutical firm Dr Reddy’s Laboratories has been hit by an unfavourable ruling in a legal case claiming it infringed …
News
lavalbldg1806696_853705

FDA approves Valeant plaque psoriasis drug despite suicide concerns

February 16, 2017 Sales and Marketing FDA, Siliq, Valeant, psoriasis

The US Food and Drug Administration (FDA) has announced that it has approved Valeant Pharmaceutical’s injectable psoriasis treatment Siliq (brodalumab) …
News
handshake-2056023_960_720

Integra bids $1.045 billion for J&J’s neurosurgery business

February 16, 2017 Sales and Marketing Codman, Integra, J&J, JJ, Johnson & Johnson

Integra, a medical technology company, have announced that it has made a binding offer to acquire Johnson & Johnson’s Codman …
News

Stada encourages bidding war, with figure of €3.5 billion mooted

February 15, 2017 Research and Development, Sales and Marketing Advent International, Cinven, Stada

Stada, the German generic drugmaker, has received two offers for takeover, with one estimated to be €3.5 billion, thought to …
News
down_arrow

Hepatitis C market set for slump as cure rates rise

February 14, 2017 Manufacturing and Production, Medical Communications, Sales and Marketing Gilead, hepatitis C

Objectively, it is the pharmaceutical industries intention to find cures for diseases and to aid patients to live a full …
News
marathon_logo

Marathon’s major misstep shows that drug pricing debate is here to stay

February 14, 2017 Manufacturing and Production, Sales and Marketing Duchenne Muscular Dystrophy, Emflaza, marathon

Marathon Pharmaceuticals’ approval, last week, by the FDA for its treatment for Duchenne muscular dystrophy would usually have been cause …
News
allergan

Allergan set to bolster ‘medical aesthetics’ unit with $2.5 billion Zeltiq deal

February 13, 2017 Manufacturing and Production, Sales and Marketing Allergan, FDA, Zeltiq

Allergan, the owner of Botox, has expanded its stake in the ‘medical aesthetics’ business by acquiring Zeltiq Aesthetics. Zeltiq has …
News

Pfizer and Flynn: How are ‘excessive’ prices for generic drugs possible and should competition authorities do more about exploitative pricing?

February 13, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, Pfizer, flynn

As last year came to a close, the headlines were rocked by the news that pharma giant Pfizer had been …
Feature

NICE turns down AZ’s chronic obstructive pulmonary disease drug

February 13, 2017 Sales and Marketing AstraZeneca, Daxas, NICE, chronic obstructive pulmonary disease

AstraZeneca’s Daxas (roflumilast) has been knocked back in draft guidance by the National Institute for Health and Care Excellence (NICE), …
News
headquarters_2_web

Lilly €200m expansion of Cork site under review

February 13, 2017 Manufacturing and Production, Sales and Marketing Eli Lilly, Ireland, cork

Eli Lilly’s planned €200m investment to its manufacturing plant in Kindsdale, County Cork, is now under-review. The expansion would bring …
News
ipsen_small

Ipsen to acquire Sanofi assets in $88 million deal

February 13, 2017 Sales and Marketing Boehringer Ingelheim, Prontalgine, Sanofi, ipsen

Ipsen has announced that it is set to enter into a definitive agreement to acquire five consumer healthcare products from …
News
The Gateway to Local Adoption Series

Latest content

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026

Altimetrik appoints Dhirendra Nath as Chief Human Resources Officer

March 12, 2026

Kindeva appoints Mike Cowhig as Chief Legal Officer

March 11, 2026

DiaMedica gets regulatory clearance from Health Canada for phase 2 preeclampsia study

March 11, 2026

Abselion establishes a US subsidiary in Massachusetts 

March 10, 2026